Other Income & Expense
Investment income and other, net
Neurocrine Biosciences Investment income and other, net increased by 8.9% to $28.10M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 29.5%, from $21.70M to $28.10M. Over 4 years (FY 2021 to FY 2025), Investment income and other, net shows an upward trend with a 120.8% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
Analysis
StatementIncome Statement
SectionOther Income & Expense
CategoryLiquidity
SignalHigher is better
VolatilityModerate
First reportedQ1 2016
Last reportedQ1 2026May 5, 2026
How to read this metric
Higher income indicates effective management of cash reserves and favorable interest rate environments.
Detailed definition
Investment income and other, net, includes interest earned on cash and cash equivalents, as well as other miscellaneous...
Peer comparison
Standard for all companies; peers with large cash balances will show higher investment income in high-interest environments.
Metric ID:
other_income_expense_investment_income_and_other_netHistorical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $900.00K | $800.00K | $700.00K | $1.00M | $1.60M | $200.00K | $1.30M | $9.80M | $10.70M | $14.50M | $18.90M | $22.30M | $22.80M | $23.40M | $22.50M | $21.70M | $20.60M | $22.20M | $25.80M | $28.10M |
| QoQ Change | — | -11.1% | -12.5% | +42.9% | +60.0% | -87.5% | +550.0% | +653.8% | +9.2% | +35.5% | +30.3% | +18.0% | +2.2% | +2.6% | -3.8% | -3.6% | -5.1% | +7.8% | +16.2% | +8.9% |
| YoY Change | — | — | — | — | +77.8% | -75.0% | +85.7% | +880.0% | +568.8% | >999% | >999% | +127.6% | +113.1% | +61.4% | +19.0% | -2.7% | -9.6% | -5.1% | +14.7% | +29.5% |
Range$200.00K – $28.10M
CAGR+106.4%
Avg YoY Growth+649.3%
Median YoY Growth+69.6%
Current Streak3 quarters growth
Business Segments
| Segment | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 |
|---|---|---|---|---|---|
| Reportable Segment | $21.70M | $20.60M | $22.20M | $25.80M | $28.10M |
| Total | $21.70M | $20.60M | $22.20M | $25.80M | $28.10M |
Investment income and other, net at Other Companies
Frequently Asked Questions
- What is Neurocrine Biosciences's investment income and other, net?
- Neurocrine Biosciences (NBIX) reported investment income and other, net of $28.10M in Q1 2026.
- How has Neurocrine Biosciences's investment income and other, net changed year-over-year?
- Neurocrine Biosciences's investment income and other, net increased by 29.5% year-over-year, from $21.70M to $28.10M.
- What is the long-term trend for Neurocrine Biosciences's investment income and other, net?
- Over 4 years (2021 to 2025), Neurocrine Biosciences's investment income and other, net has grown at a 120.8% compound annual growth rate (CAGR), from $3.80M to $90.30M.
- What does investment income and other, net mean?
- Income earned from cash investments and other non-core activities.